/consists of the construction of a new 174m² single storey modular building
Alexion Pharmaceuticals, Monksland, Athlone
0.411 ha · Granted · permission to Jul 2031
Planning application 2660198 to Roscommon County Council: /consists of the construction of a new 174m² single storey modular building extension, at Alexion Pharmaceuticals, Monksland, Athlone. Granted by the council on 23 June 2026. The register gives the permission's end as 27 July 2031.
Timeline
- Application lodged
- Council granted
- Permission ends (date on the register)
The end date is the one the council register states. An extension or a commencement changes it.
Key facts
Proposed development
Permission for development which will consist/consists of the construction of a new 174m² single storey modular building extension with external signage to the north elevation of the existing Fill Finish Warehouse and all associated ancillary site works including the demolition of existing external concrete stairs, existing concrete ramps and existing sections of footpath and associated railings; the construction of a new external concrete footpath, concrete stairs and associated railings; and modifications to the underground services at the Alexion manufacturing facility. This development will be carried out on a site, which comprises an activity requiring an Integrated Pollution Prevention and Control (IPPC) Licence, register number P1094-01, now deemed an Industrial Emissions Licence (IEL), at
Planning status
Permission was granted on 23 Jun 2026. The four-week appeal period has passed with no appeal recorded, so the permission is final. Works can start once a commencement notice is lodged; the register gives its end as 27 Jul 2031.
Is this your application?
Say it is yours and you will see which building firms and trades have asked to work on it, with the contact details they chose to leave. It is free and takes an email address. Nothing is shared with anyone unless you choose to contact them.
Nearby applications
Other applications on the Roscommon register close to this address.
- 2560250Alexion Pharmaceuticals, Monksland, Athlone Co. RoscommonClosed
Development consisting of the construction of 1) a new 2-storey storage building extension to the north elevation of the existing Fill Finish Line Warehouse…
- 2560264Alexion Pharmaceuticals, Monksland, AthloneGranted
Development that will consist of the construction of 1) a new 2-storey storage building extension to the north elevation of the existing Fill Finish Line…
- 2660140Alexion Pharmaceuticals, Monksland, AthloneClosed
Construction of a 174m2 single storey modular building extension to the existing Fill Finish Warehouse and all associated ancillary works…
- 2560475Alexion Pharmaceuticals, Monksland, AthloneGranted
Development which will consist of the construction of 98 sqm single storey security building max 4.1m high with external signage located adjacent to the main…
- 2660121Monksland, Athlone, Co. RoscommonClosed
Development which will consist of extending the first floor of Building 15 by constructing a single-storey external pergola measuring 40.75 m²…
- 2660147Monksland, Athlone, Co. RoscommonClosed
Development, the development will consist of extending the first floor of Building 15 by constructing a single-storey external pergola measuring 40.75 m²…
Related
About this page: the facts above come from the statutory public planning register kept by Roscommon County Council and are refreshed weekly (last updated 21 Sept 2026). Applicant names and contact details are not shown. Status labels are PlanningLeads' plain-language reading of the register status and the "Use" label is classified by AI from the public description (see how we use AI); neither is legal advice and the council's file is the record. How we handle this data: privacy notice.
Remove my application from this page
If this is your application and you would rather it did not appear here, tell us and we will take the page down. No account, no questions asked: we only email you a link to confirm it was you. This is your right to object under GDPR Article 21.